
Brian E. Mcdowell
Examiner (ID: 2181, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1622 |
| Issued Applications | 1025 |
| Pending Applications | 135 |
| Abandoned Applications | 522 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16268735
[patent_doc_number] => 20200270222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => BENZOTHIAZOL COMPOUNDS AND METHODS USING THE SAME FOR TREATING NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/931827
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931827
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931827 | Benzothiazol compounds and methods using the same for treating neurodegenerative disorders | May 13, 2020 | Issued |
Array
(
[id] => 18294888
[patent_doc_number] => 20230104574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => FGFR INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/595257
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 177722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 668
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595257
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595257 | FGFR INHIBITORS AND METHODS OF USE THEREOF | May 11, 2020 | Pending |
Array
(
[id] => 18294888
[patent_doc_number] => 20230104574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => FGFR INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/595257
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 177722
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 668
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595257
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/595257 | FGFR INHIBITORS AND METHODS OF USE THEREOF | May 11, 2020 | Pending |
Array
(
[id] => 18559748
[patent_doc_number] => 11724982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
[patent_app_type] => utility
[patent_app_number] => 16/868343
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 49675
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868343
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868343 | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration | May 5, 2020 | Issued |
Array
(
[id] => 16435600
[patent_doc_number] => 20200352925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => AMIDE DERIVATIVES USEFUL IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/867249
[patent_app_country] => US
[patent_app_date] => 2020-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 477
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16867249
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/867249 | Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases | May 4, 2020 | Issued |
Array
(
[id] => 16252056
[patent_doc_number] => 20200261430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => ESTROGEN RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/867017
[patent_app_country] => US
[patent_app_date] => 2020-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16867017
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/867017 | Estrogen receptor modulators | May 4, 2020 | Issued |
Array
(
[id] => 16252054
[patent_doc_number] => 20200261428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => ESTROGEN RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/866900
[patent_app_country] => US
[patent_app_date] => 2020-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866900
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866900 | Estrogen receptor modulators | May 4, 2020 | Issued |
Array
(
[id] => 16252055
[patent_doc_number] => 20200261429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => ESTROGEN RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/866995
[patent_app_country] => US
[patent_app_date] => 2020-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866995
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866995 | Estrogen receptor modulators | May 4, 2020 | Issued |
Array
(
[id] => 16252076
[patent_doc_number] => 20200261450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 16/865685
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/865685 | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | May 3, 2020 | Abandoned |
Array
(
[id] => 18366017
[patent_doc_number] => 20230147608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => HALOGENATED ZINC PHTHALOCYANINE PIGMENT AND PRODUCTION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/296665
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296665
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296665 | HALOGENATED ZINC PHTHALOCYANINE PIGMENT AND PRODUCTION METHOD THEREFOR | Apr 29, 2020 | Pending |
Array
(
[id] => 16238143
[patent_doc_number] => 20200255377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => CARBAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/859103
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16859103
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/859103 | Carbazole derivatives | Apr 26, 2020 | Issued |
Array
(
[id] => 16743233
[patent_doc_number] => 10968207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Methods for preparing oltipraz
[patent_app_type] => utility
[patent_app_number] => 16/854480
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16811
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854480
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854480 | Methods for preparing oltipraz | Apr 20, 2020 | Issued |
Array
(
[id] => 17513588
[patent_doc_number] => 11292716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Photo-catalytic splitting of water using self-assembled metalloporphyrin 2D-sheets
[patent_app_type] => utility
[patent_app_number] => 16/853870
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 4200
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853870
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853870 | Photo-catalytic splitting of water using self-assembled metalloporphyrin 2D-sheets | Apr 20, 2020 | Issued |
Array
(
[id] => 16421838
[patent_doc_number] => 20200347036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => SOLID FORMS OF AN HIV PROTEASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/849201
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849201
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849201 | SOLID FORMS OF AN HIV PROTEASE INHIBITOR | Apr 14, 2020 | Abandoned |
Array
(
[id] => 16206494
[patent_doc_number] => 20200239484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => METHOD FOR PREPARING PYRROLO[3,2,-D]PYRIMIDINE COMPOUND, AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/847394
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847394
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847394 | METHOD FOR PREPARING PYRROLO[3,2,-D]PYRIMIDINE COMPOUND, AND INTERMEDIATES THEREOF | Apr 12, 2020 | Abandoned |
Array
(
[id] => 16398714
[patent_doc_number] => 20200339572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => NOVEL SELECTIVE CDK4/6 INHIBITOR AND PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/847487
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847487 | Selective CDK4/6 inhibitor and preparation thereof | Apr 12, 2020 | Issued |
Array
(
[id] => 16326760
[patent_doc_number] => 20200297725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => ALLOSTERIC BCR-ABL PROTEOLYSIS TARGETING CHIMERIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/825878
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825878
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/825878 | ALLOSTERIC BCR-ABL PROTEOLYSIS TARGETING CHIMERIC COMPOUNDS | Mar 19, 2020 | Abandoned |
Array
(
[id] => 16893350
[patent_doc_number] => 11034885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material
[patent_app_type] => utility
[patent_app_number] => 16/819175
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3890
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16819175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/819175 | Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material | Mar 15, 2020 | Issued |
Array
(
[id] => 16893350
[patent_doc_number] => 11034885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material
[patent_app_type] => utility
[patent_app_number] => 16/819175
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3890
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16819175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/819175 | Light emitting material, manufacture method thereof and organic light emitting diode using the light emitting material | Mar 15, 2020 | Issued |
Array
(
[id] => 16156491
[patent_doc_number] => 20200216478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, AND DISPLAY ELEMENT
[patent_app_type] => utility
[patent_app_number] => 16/819377
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16819377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/819377 | Electrochromic compound, electrochromic composition, and display element | Mar 15, 2020 | Issued |